Kindstar Globalgene Technology, Inc. Stock
Equities
9960
KYG5262E1044
Healthcare Facilities & Services
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.56 HKD | -2.50% | +1.30% | -7.14% |
Sales 2023 | 967M 134M 1.04B | Sales 2024 * | 1.32B 182M 1.43B | Capitalization | 1.41B 195M 1.52B |
---|---|---|---|---|---|
Net income 2023 | 41M 5.66M 44.29M | Net income 2024 * | 110M 15.18M 119M | EV / Sales 2023 | 1.51 x |
Net cash position 2023 * | - 0 0 | Net cash position 2024 * | - 0 0 | EV / Sales 2024 * | 1.07 x |
P/E ratio 2023 |
35.9
x | P/E ratio 2024 * |
13.5
x | Employees | 3,125 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 53.13% |
1 day | -2.50% | ||
1 week | +1.30% | ||
Current month | +6.12% | ||
1 month | +7.59% | ||
3 months | +1.30% | ||
6 months | +2.63% | ||
Current year | -7.14% |
Managers | Title | Age | Since |
---|---|---|---|
Shi Ang Huang
CEO | Chief Executive Officer | 66 | 11-02-21 |
Hai Jie Chai
DFI | Director of Finance/CFO | 46 | 20-12-03 |
Zan Bing Tu
COO | Chief Operating Officer | 52 | 20-12-03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Zuie Chin Huang
BRD | Director/Board Member | 58 | 12-01-29 |
Xin Ping Xia
BRD | Director/Board Member | 59 | 21-02-22 |
Shi Ang Huang
CEO | Chief Executive Officer | 66 | 11-02-21 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 1.56 | -2.50% | 26 500 |
24-04-26 | 1.6 | +2.56% | 728,500 |
24-04-25 | 1.56 | 0.00% | 94,000 |
24-04-24 | 1.56 | +1.30% | 221,000 |
24-04-23 | 1.54 | 0.00% | 412,500 |
Delayed Quote Hong Kong S.E., April 29, 2024 at 02:18 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.14% | 195M | |
-16.58% | 8.25B | |
+39.20% | 3.58B | |
-39.11% | 2.46B | |
-8.06% | 2.46B | |
-6.68% | 2.38B | |
-19.01% | 1.55B | |
-40.66% | 1.21B | |
+7.56% | 1.11B | |
-14.88% | 1.03B |
- Stock Market
- Equities
- 9960 Stock